Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways

被引:804
|
作者
Lagna, G
Hata, A
HemmatiBrivanlou, A
Massague, J
机构
[1] MEM SLOAN KETTERING CANC CTR,NEW YORK,NY 10021
[2] ROCKEFELLER UNIV,HOWARD HUGHES MED INST,MOL EMBRYOL LAB,NEW YORK,NY 10021
关键词
D O I
10.1038/383832a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
THE TGF-beta/activin/BMP superfamily of growth factors signals through heteromeric receptor complexes of type I and type II serine/threonine kinase receptors(1) The signal originated by TGF-beta-like molecules appears to be transduced by a set of evolutionarily conserved proteins known as SMADs, which upon activation directly translocate to the nucleus where they may activate transcription(2), Five SMAD proteins have so far been characterized in vertebrates(1), These factors are related to the mediator of decapentaplegic (dpp) signalling, mothers against dpp (Mad), in Drosophila(3) and to the Sma genes from Caenorhabditis elegans(4). Smad1 and Smad2 have been shown to mimic the effects of BMP and activin, respectively, both in Xenopus and in mammalian cells(2,5-9), whereas Smad3 (a close homologue of Smad2) and the related protein DPC4, a tumour-suppressor gene product(10), mediate TGF-beta actions(11). We report here that DPC4 is essential for the function of Smad1 and Smad2 in pathways that signal mesoderm induction and patterning in Xenopus embryos, as well as antimitogenic and transcriptional responses in breast epithelial cells, DPC4 associates with Smad1 in response to BMP and with Smad2 in response to activin or TGF-beta. DPC4 is therefore a regulated partner of SMADs that function in different signalling pathways of the TGF-beta family.
引用
收藏
页码:832 / 836
页数:5
相关论文
共 50 条
  • [1] DPC4/SMAD4 and TGF beta-like signals in pancreatic carcinogenesis
    Cetta, F
    Bon, G
    Nounga, H
    Cariati, A
    Mazzarella, L
    GASTROENTEROLOGY, 2003, 124 (04) : A350 - A350
  • [2] TGF-beta signalling through the Smad pathway
    Massague, J
    Hata, A
    Liu, F
    TRENDS IN CELL BIOLOGY, 1997, 7 (05) : 187 - 192
  • [3] TGF-beta signalling from cell membrane to nucleus through SMAD proteins
    Heldin, CH
    Miyazono, K
    tenDijke, P
    NATURE, 1997, 390 (6659) : 465 - 471
  • [4] Smad4/DPC4
    McCarthy, Aoife J.
    Chetty, Runjan
    JOURNAL OF CLINICAL PATHOLOGY, 2018, 71 (08) : 661 - 664
  • [5] Synthetic triterpenoids activate TGF-beta/SMAD signalling
    Suh, N
    Roberts, A
    Heiss, E
    Place, A
    Williams, C
    Risingsong, R
    Reffey, S
    Honda, T
    Gribble, G
    Miyazono, K
    Itoh, S
    ten Dijke, P
    Sporn, M
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1230S - 1230S
  • [6] Point mutations in the tumor suppressor Smad4/DPC4 enhance its phosphorylation by GSK3 and reversibly inactivate TGF-beta signaling
    Demagny, Hadrien
    De Robertis, Edward M.
    MOLECULAR & CELLULAR ONCOLOGY, 2016, 3 (01):
  • [7] Dual role of the Smad4/DPC4 tumor suppressor in TGF beta-inducible transcriptional complexes
    Liu, F
    Pouponnot, C
    Massague, J
    GENES & DEVELOPMENT, 1997, 11 (23) : 3157 - 3167
  • [8] Smad6 inhibits signalling by the TGF-beta superfamily
    Imamura, T
    Takase, M
    Nishihara, A
    Oeda, E
    Hanai, J
    Kawabata, M
    Miyazono, K
    NATURE, 1997, 389 (6651) : 622 - 626
  • [9] DPC4 (SMAD4) mediates transforming growth factor-beta 1 (TGF-beta 1) induced growth inhibition and transcriptional response in breast tumour cells
    deWinter, JP
    Roelen, BAJ
    tenDijke, P
    vanderBurg, B
    vandenEijndenvanRaaij, A
    ONCOGENE, 1997, 14 (16) : 1891 - 1899
  • [10] Identification of Smad7, a TGF beta-inducible antagonist of TGF-beta signalling
    Nakao, A
    Afrakhte, M
    Moren, A
    Nakayama, T
    Christian, JL
    Heuchel, R
    Itoh, S
    Kawabata, N
    Heldin, NE
    Heldin, CH
    tenDijke, P
    NATURE, 1997, 389 (6651) : 631 - 635